Table 4.
Total volume of intraoperative blood loss | Unadjusted P value | Adjusted P valuea | |
Implant type, median (IQR) | 0.052 | 0.005 | |
Stemless aTSA | 298.3 (212.6-402.8) | ||
Short-stem aTSA | 359.7 (253.9-415.0) | ||
Age, Spearman correlation | r = −0.060 | 0.503 | —b |
Sex, median (IQR) | 0.031 | 0.001 | |
Female | 299.7 (212.6-383.2) | ||
Male | 357.2 (257.9-455.6) | ||
BMI (Spearman correlation) | r = 0.089 | 0.312 | 0.041 |
ASA, median (IQR) | 0.806 | —b | |
1-2 | 326.3 (229.2-412.1) | ||
≥3 | 323.0 (235.1-406.7) | ||
ACCI (Spearman correlation) | r = 0.022 | 0.803 | —b |
Prior ipsilateral arthroscopy (median (IQR)) | 0.631 | —b | |
No | 318.7 (218.1-412.1) | ||
Yes | 346.2 (266.0-402.2) | ||
Hemovac use, median (IQR) | 0.074 | —b | |
No | 274.8 (182.9-400.4) | ||
Yes | 337.1 (237.8-412.1) | ||
Transexamic acid use, median (IQR) | 0.704 | —b | |
No | 299.6 (280.7-400.4) | ||
Yes | 326.3 (225.5-412.0) | ||
Anesthesia, median (IQR) | 0.441 | —b | |
General alone | 246.9 (151.5-412.1) | ||
General/regional | 326.3 (232.7-409.7) | ||
Use of augmented polyethylene, median (IQR) | 0.344 | —b | |
No | 312.9 (232.7-404.9) | ||
Yes | 349.7 (221.8-460.6) | ||
Surgical side, median (IQR) | 0.482 | —b | |
Right | 318.1 (239.5-419.4) | ||
Left | 325.4 (191.4-405.2) |
ACCI = age-adjusted Charlson Comorbidity Index, ASA = American Society of Anesthesiologists, IQR = interquartile range
Adjusted P values were obtained from nonparametric analysis of covariance. This analysis was based on the ranks of total volume of intraoperative blood loss.
Variables did not remain in the nonparametric analysis of covariance model at a 0.05 significance level.